We have previously shown that cationic proteins localize to the dermal-epidermal junction (DEJ) after i. v. injection in experimental animals. In the present studies, cationized rabbit lgG was used as antigen for induction of chronic serum sickness in C57BL/6J mice over a period of 4 weeks. The formation of immune deposits was examined by immunofluorescence microscopy at weekly intervals during chronic antigen administration and at 7 weeks from the initiation of studies.
We have previously shown that cationic proteins localize to the dermal-epidermal junction (DEJ) after i. v. injection in experimental animals. In the present studies, cationized rabbit lgG was used as antigen for induction of chronic serum sickness in C57BL/6J mice over a period of 4 weeks. The formation of immune deposits was examined by immunofluorescence microscopy at weekly intervals during chronic antigen administration and at 7 weeks from the initiation of studies.
Chronic administration of the cationized antigen led to hnmune complex deposits at the DEJ, while administration of the same antigen in native form did not lead to these deposits. Junctional immune deposits increased with higher doses of cationized antigen and paralleled renal extraglomular deposition in intensity, persistence, and morphology. Mice given cationized antigen also demonstrated vascular immune complex deposits without complement, while mice given native antigen had complement deposits and developed perivascular inflammation. No inflammation or complement deposition was detected at the DEJ in either group.
Charge properties of circulating antigens are important in determining tissue sites of immune complex deposition and inflammation. Circulating cationic antigens can lead to immune deposits at the DEJ.
Deposit ion of circulating immune complexes, as a cause of inflammatory human dermal disorders, has been suspected in a number of skin diseases [1] . Opie [2] , in 1924, showed that the local inflammation produced by intradermal injection of egg album in in rabbits depended on the antibody titer, implicating immune complexes in the induction of inflammation. In animal models of acute and chronic serum sickness, investigators have demonstrated the occurrence of vascular lesions in t issues of rabbits [3] . mice [4] , and guinea pigs [5] . Dixon eta! [6] demonstrated the presence of both antigen and antibody in these vascular lesions, again implicating immune complexes in their pathogenesis.
In these experimental models, no comments were made about cutaneous deposition of immune complexes and inflammation of the skin. Rich and Gregory noted "petechiae" in several rabbits that developed vascular lesions after immunization with Manusc ript received February 4, 1985; accepted for publication July 17, 1985. This work was supported by grants AM 11476 and T32AM 07108 from the Nationa l Institute of Arthritis, Diabetes, Digestive and Kidney Diseases.
* Presented in part at the Annual Meetin g of The Society for Investigative Derm ato lo!,')', Was hingto n, D.C., May 7-9, 1984 [3 ] . These animals developed inflammation in tissues such as heart, bladder wall, and testis, but no comments were made on skin inflammation. However, a cutaneous Arthus reaction could be induced simultaneously with the spontaneous appearance of lesions in other organs [7] , or when free antibody appeared in circulation (6] . In a large study, Brentjens et al (8] examined 161 rabbits chronically immunized with bovine serum albumin and found no dermal-epidermal junctional deposits. Mice immunized chronically with oral ovalbumin developed renal lgA deposits but no skin deposits [9] . We have previously shown in mice that cutaneous localization of immune complexes is related to immune complex lattice and charge, in that large-latticed immune complexes formed with cationic antibodies deposit and persist at the dermalepidermal junction [10] . In the present studies we have induced chronic serum s ickness in mice with native or cationic rabbit lgG as antigens, and have followed the antibody response as well as tissue deposition, wit h particular attention to the dermal vessels and dermal-epiderma l junction (DEJ).
MATERIALS AND METHODS

Preparation and Characte rization of Native, Aggregated, and Cationized. Antigen
Rabbit monomeric IgG (RlgG) was purified from rabbit fraction II (Miles Laborato ries, Elkhart, Indiana) by gel filtration over a Sephadex G-200 column (Pharmacia Fine Chemicals Pharmacia, Inc., Piscataway, New J ersey) , equilibrated with pH '8.0 borate-buffered saline (BBS) consisting of 0.2 M borate, and 0.15 M NaCI. Aliquots of t~e purified RlgG were heat aggregated in a water bath at 63•C for 10 mm to render this material more immunogenic. Cationic RlgG (RigGED) was prepared by ethylene diamine linkage to reactive ca rboxyl groups by a water-solubl e carbodiimide reaction, as previously described [ 11) . A t rini trobenze ne -sulfonic acid (TNBS) assay was performed as described by Habeeb [1 2) and modified by Gauthier et al [11) . Some preparations were trace-labeled wit h 125 1 as previously described [11] .
The a ntigen preparations were characterized on linear 10-30% sucrose density gradients as previously described [10) .
lsoelectric focusing was performed on a Pharmacia fl at bed appa ratus (Pharmacia Fine Chemicals) usin g standard procedures [11) . Focusmg was perform ed with 20-1 Il samples at 20 W for 1.5 h after 0.5 h of prefocusing. The ge l was stained for 1-2 h with Coomass1e Blue and destained ove rnight before drying.
Determination of S eru.m Antibody Levels Du.ring the Cou.rse of I mmu.nization
A radioimmunoassay was employed to assess the serum antibody level. Tests were performed in duplicate. Ten-microliter sa mples of test sera were added to 1.0 11 g and 0.1 11g of [ 125 I)RJgG in 10 11l of BBSm a 1.5-ml microfu ge tube (Beckman Instruments, Inc., Palo Alto, Cahforni a). The samples were allowed to react in a water bath at 37· c for 1 h prior to the addition of 80 11l of goat antimouse IgG (N. L. Cappel Laborato ries, Cochranville, Pennsylvania) t hat had been passed ove r a Sepharose CL4B-RigG affinity column to remove antibodies reactive with RigG. The samples were aga in allowed to react for 1 h at 37•c and were then stored for 16 h at 4 · c prior to centrifugation at 10,000 rpm for 5 min in the Beckman Microfuge 12 (Beckman Instruments, Inc.) Percent bound was calculated by determinin g t he radioactivity of the 50 11l supernata nt (S) and 50 11l residual (R) fraction as (R -S/R + S) X 100.
The assay was standardized with sera from mice immunized by the sa me experimental protocol, and collected 2 weeks after the initiation 560 JOSELOW , GOW N, AND MANNIK of immunization. The concentration of the se rum was adjush;d to prec ipitate approx im ately 50% of0.1 11g RlgG and s 50% of 1 11g RigG.
In separate experiments 80 11l of t he prepared goat antimouse lgG precipi tated greater t han 95 % of 100-11g sa mples of radiolabeled mouse lgG in 10 J1.1 BBS, and 5 Jl.g of labeled mouse IgG added to 10-Jl.l sa mples of norm al mouse sera, and precipitated less than 10% of 1.0 or 0.1 11g of labeled RlgG in BBS.
Immunofluorescence M icroscopy, Histology, and Electron Microscopy
Skin from tai l, lip, fl ank, and ear, and renal tissue were obtained afte r sacrifi ce of mice. These tissues were embedded in Tissue Tek 11 OCT (Ames Co mpany, Elkhart, Indiana) and frozen. Four-mic romete r sections were cut, stain ed, exa mined, and graded as previously desc ribed (10] . The fo llow ing 11uoresceinated antise ra were used: goat antirabbit l gG (Ka ll estad Laboratories, Au stin, Texas); goat antimouse C3 and goat ant imouse IgG (N. L. Cappel Laboratories). T he antisera were furth er purified with either RlgG or mouse whole-serum columns to render them monospecific. The specificity was verified with agaroseantige n beads as previously described [13] . A grad ing scale (0 to 4+) was used as prev iously desc ribed for kidney [11] and skin [12] . Briel1y t he sco ring fo r skin was: 4+, dense deposits visible at lOOX; 3+ , den se deposits visible in most fields at 400x; 2+, dense deposits vi sible in some fi elds (10-50%) at 400x; 1+, deposits visibl e in less t han 10% of fi elds at 400x; trace, fai nt deposits visible in some fie lds at 400X. A Zeiss 11uoresce nce microscope (Zeiss, Oberkoc hen, F.R.G .) was used. Photographs were taken on T ri -X Pan ASA 400 film (Eastman Kodak, Roc heste r, New York) with a 30-s exposure time.
For hi stology, tissues were stored in gluta ralde hyde/cacodylate buffer (0.1 M sodium cacodyl ate, 6% glutaraldehyde) at 4"C. Tissues were cut in 4-Jl.m sections and stain ed with hematoxylin and eosin. A grad ing scale of 0 to 3+ was used: 0, no inflammatory cell s; 1+, 1-3 inflamm atory cells; 2+, 4-10 cells; and 3+ , greater than 10 cells around indi vidual blood vessels at 400x.
Electro n microscopy was performed on kidney sections as prev iously described [14] .
Experimental Design.
Female C57BL/6J mi ce (Jackson Laborato ries, Bar Harbor, Maine) were divided into 4 groups. All anim als received a primary immunization wit h 1.0 mg of heat-aggregated RigG in complete Freund 's adjuva nt s.c. on day -14 and were boosted at day -7 wit h 1.0 mg of heataggregated RlgG in in com plete Freund's adjuvant. Chronic ta il vein injections we re begu n 1 week later, on day 0. The first group rece ived l.O mg RigG in 0.5 ml BBS chronic i.v. injections on Monday, Wednesday, and Friday. The second group received 1.0 mg RigGEIJ, the third group 5.0 mg R lgG 8 n, an d t he fourth group 0.5 ml BBS only, all on the same schedule. Injections were co ntinued for 4 weeks. Three mice in eac h group were sac rificed at weeks 1, 2, 3, and 4, 16 h after t he last injection. T hree mice in eac h group were sac rificed at 7 weeks, i.e., 3 weeks afte r t he fin al injection of antige n. In separate experiments, 2 mice were sac rificed at weeks 1, 2, 3, and 4, 4 h after t he last injection of antigen.
Urin e sa mples were chec ked at the end of eac h wee k for protein wit h Uri stix (Ames Company). Fifty-microliter samples of blood were obta in ed from retroorbital plex us prior to injections on Mondays, and the harvested serum was sto red at -70"C.
RESULTS
Characterization of Antigens
RlgG a nd R igGED we re s hown to be monomeric on sucrose densit y gradie n ts (SDGs ). In heat-aggregated RigG, 45% of protein radioactiv ity sedimented faster t h an 7S. The TNBS assay s howed the average number of added amin o groups o n RigGr,:D to range from 20-30 . On isoelectric focusing t he majority of RigGw h a d a pi greater than 9 .3 with a trai ling edge of less a ltered protein.
Dermal Localization of Immune Deposits and Inflammation
All tissues we re stained with fluoresceinated goat anti mouse IgG, goat a ntimouse C3, a nd goat antii a bbi t l gG. Most sections of s kin from different locations stained s imilarly, but where regional diffe re nces occurred t his is n oted .
At t he DEJ, RlgG as an t igen was ide nt ifiable only after t h e c hroni c administration of cationized RlgG . RlgG was detected con sistently at t r-1+ levels in t he RigG ED (1 mg) group and at Vol. 85, No. 6 1-2+ (Table 1) . Diffuse dermal deposits without clear vascular patterns occurred in the RigG (1 mg), RigGED (1 mg), and RigGED (5 mg) groups at tr-1 + levels. The same t issues were also examined for t he presence of mouse IgG and mouse C3. The mice given RigGEo showed mouse lgG deposits at the DEJ after antigen administration that increased with t ime and with higher dose of antigen. The RigG ED (1 mg) group had depos its increasing from 0-tr at 1 week, 1-2+ at 2 weeks, to 1-2.5+ at 3 weeks, 1-1.5+ at 4 weeks, and declined to n ear trace levels at 7 weeks, 3 weeks after antigen injections were stopped (Table II) . There was slight regional variation in positivity, most marked at 3 weeks (Fig 
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weeks, 1-2+ at 4 weeks, and 1.5+ at 7 weeks, again 3 weeks after injections were stopped (Fig 2) . With the injection of unaltered RigG and in the control group given only buffer, no deposits of mouse IgG were found at the DEJ. All skin specimens were examined for vascular and interstitial deposits of mouse IgG, but only tr-1 +deposits were found inconsistently in the 2 RigGED and the RigG groups over the course of the experiment. Mouse C3 was not detected in any skin sections.
Because we found perivascular inflammation without demonstr able immune deposits, we subsequently sacrificed mice 4 h (instead of 16) after the last injection of antigen. The RlgG (1 mg) group had granular vascular deposits of antigen, antibody, and comp lement at this time point (Table III) . The RigGED (1 mg) group had more diffuse perivascular and trace junctional deposits of antigen and antibody without complement (Fig 3) .
For comparison, in the same mice deposition of the antigen and mouse IgG and mouse C3 was examined in glomeruli and interstitial areas. The deposits of rabbit lgG were comparable to t he deposits of mouse IgG (Table IV) . In the RigGED (1 mg) group, deposition increased from 2+ at 1 week, to 2.5+ at 2 weeks, 3+ at 3 weeks, 2.5+ at 4 weeks, and remained as intense at 7 weeks (Fig 4) . A glomerular capillary loop pattern predominated with extraglomerular tubular basement membrane staining as well: 1 + at 1, 2, and 3 weeks, and declined thereafter.
The RigGED ( 5 mg) group had more intense deposits at all t ime points than the RigG ED (1 mg) group: 2+ at 1 week, 3.5+ at 2 weeks, 4+ at 3 and 4 weeks, and 3+ at 7 weeks. Extraglomerular staining in the RigGED (5 mg) group was 2+ throughout. The glomerular pattern again showed capillary loop with tubular basement membrane staining. The RigG (1 mg) group, in contrast, had lesser deposition only in a mesangial pattern: 1.5+ at 1 week, and 2+ at all later time points. Furthermore, no extraglomerular staining was found in this group. Mouse C3 was found at tr-1 + levels in the RigGED (1 mg) group, trace Histologic specimens of skin showed varying degrees of mflammation (Table V) . Inflammatory infiltrates were predominantly perivascular with mixed cell infiltrat ion in a deep dermal or subcutaneous location (Fig 5) . The infiltrates were mostly lymphohistiocytic with sparse (< 10%) neutrophils. This react ion pattern was most marked in t he RlgG (1 mg) group where dense perivascular infiltrates occurred at 3-4 weeks, even persisting to 7 weeks. Accumulation of inflammatory cells was not seen at t he DEJ in any experimental group.
Renal Histology, Proteinuria, and Electron Microscopy
Kidney pathology did not differ significantly in any experimental group at any time point but did show mild hypercellularity and mesangial thickening, as compared to the control group.
Proteinuria developed in all experimental groups at trace levels at 1-2 weeks, and 1-2+ levels t hereafter; the BBS-treated groups had only 0-tr levels throughout t he study.
Electron microscopy revealed subepithelial, as well as subendothelial, mesangial, and interstitial deposits in the RigGED (5 mg) group more so than in the RigGED (1 mg) group, while the RigG (1 mg) group showed only mesangial deposits. Ri gGED (1 mg) 16 h afte r last dose.
Level of Seru.m Antibody to Rabbit JgG
As determined by t he radioimmunoassay, normal mouse sera had 11.11 ± 5.0% background antigen binding (Fig 6) . Reference sera after 2 immunizations with heat-aggregated RigG, collected at day 0 before the chronic antigen administration, developed 51.3 ± 4.2% binding of 0.1 f..Lg antigen. The serum a ntibody levels in t he RigG ( 1 mg), RigGED (1 mg), and BBS groups did not vary significa ntly, except at 1 week when the RlgG (1 mg) group had a much higher measurable level. The RigGED (5 mg) group, however, had significantly lower serum a nt ibody levels (p < .05) during t he period of chronic antigen injections than in other groups of mice. At 7 weeks, all groups had similar serum antibody levels, which represented a significa nt increase for the RigGED (5 mg) group. 
DISCUSSION
The presented data indicate that antigen charge is an important parameter determining tissue sites of immune deposit formation. Chronic administration of cationized rabbit lgG to immunized mice resulted in immune deposits at t he DEJ while chronic administration of the same antigen in native form did not cause these deposits. The presence of immune complexes was inferred by immunofluorescence microscopy from the simultaneous appearance of antigen and antibody in concurrent sections. Schubert et al [15] . and Stanley et a l [16) have found that the interstitial space and the DEJ of the skin contain anionic glycoproteins. Thus, charge-charge interactions with cation ic macromolecules may be responsible for immune deposits at these sites.
These deposits most likely represent a combination of in situ formatio n at the DEJ and intravascular formation with subsequent junctional localization of the complexes, as has been demonstrated previously for immune complexes with a cationic antibody [10) . Extrapolating from our radioimmunoassay data, we can conclude that serum antibody represents a small fraction of circulating lgG . Therefore, experimental conditions would favor a high degree of antigen excess, leading to smalllatticed complexes and free antigen available for in situ deposition. Cationized rabbit IgG has been previously shown to have a rapid 2-phase clearance from circulation with less than 10%
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remaining at 12 h afte r i.v. injection (11] . These conditions could decrease the level of antigen excess in circulation and favor form ation of large-lattice intravascular complexes. Apart from size, however, complexes with cationic constituents have electrostatic forces holding them to tissues. Indeed, junctional deposits persisted 3 weeks after the last injection of cationic antigen , suggesting very avid binding.
The extraglomerular renal deposits paralleled the immune deposits at the DEJ in intensity, J:.ersistence, and linear morphology. Glomerular deposits occurred in a capillary loop pattern with increased complement deposition in the cationized antigen-stimu lated groups, confirming the work of Gallo et al [1 7) after injection of cationic antigen. E lectron microscopy revealed subendothelial electron-dense deposits, greater than s ubepithelia l and extraglomeru lar ones, in the cationized antigen groups, which were even more prominent in the higher dose group. The unaltered antigen group developed mesangial depos its, as has also been previously reported [17] .
Increasing the dose of cationized antigen (5 mg per injection) led to increased deposition in t he kidney as well as at t he DEJ. The low level of serum antibody in this group during the chronic antigen adm inistration, t herefore, must represent immune complex formation with the synt hesized antibody, contributing in part to enhanced tissue deposition . Despite the stepped-up deposition , mouse C3 could not be detected at t he DEJ. Mouse C3, however, was present in the glomeruli, indicating that complement-fixing antibodies to the injected antigen had been synthesized. Therefore, the reason for t he absence of C3 deposits at t he DEJ may be related to t he distance between fixed anionic sites at t he junction. If the distance is such that rearra ngement or condensation into large deposits is not favored, contra ry to what has been observed in renal glomeruli [18] , then the small -latticed complexes of cationic antigen and mouse an tibodies may not suffice for complement activation.
Hi stologic Ram pies revealed pathologic changes of mixed cell , perivascular infiltration only in the dermis and subcutaneous tissue of the mice given the native antigen on the chronic schedule. Four hours after injection of antigen, vascular deposition of antigen , antibody, and complement occurred in t his group. The immunofluorescent staining pattern was similar to that seen after injection of a single bolus of preformed complexes (10] . The cationic group had more diffuse perivascular and interstital deposits of antigen and antibody (Fig 3) , but mouse C3 was absent. Complexes formed with unaltered rabbit lgG persist longer in circulation than those formed with cationized rabbit IgG [11] . This factor may have contributed to enhanced deposition of immune complexes in small dermal vessels.
These vascular and perivascular immune deposits were not detectable 16 h after antigen injection. After a single i.v. bolus of preformed comp lexes immune deposits were previously shown to be waning after 12 h [10) . Also, immune deposits were not detectable in dermal vessels of guinea pigs 8-18 h after induction of an Arthus reaction [19] . Furthermore, in patients with small-vessel vasculitis lesions over 24 h old, immune deposits could no longer be found [20] . Phagocytosis of immune complexes is the most likely cause for the brief presence of immune deposits, since neutrophils were seen by 16 h after antigen injection. Thus, t he inflammation in vessels is related to transient deposition of immune complexes and complement components.
These experiments show that the charge properties of circulating antigens a re important in quantitative and site-specific formation of deposits. The DEJ is accessible to intravascular cationic antigens, and can lead to antibody deposition at this site. The data presented here document t his in a chronic serum sickness model in mice. A previous study indicated that positively charged immune complexes have access to this site from circulation (10] . These studies collectively suggest that the DEJ deposits of immunoglobulins in human diseases also may arise by charge-charge interactions. The fixed negative charges at the DEJ may bind positively charged immune complexes, if these complexes can reach the DEJ. Alternatively, positively charged antigens can bind to t hese negative charges and then combine with antibodies to form immune deposits locally.
